Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc

$ 24.37 +0.25 (+1.04%) 01:21 PM EST
P/E:
152.13
P/B:
3.78
Market Cap:
$ 1.38B
Enterprise V:
$ 1.01B
Volume:
172.39K
Avg Vol (2M):
656.90K
Also Trade In:
Volume:
172.39K
Market Cap $:
1.38B
PE Ratio:
152.13
Avg Vol (2-Month):
656.90K
Enterprise Value $:
1.01B
PB Ratio:
3.78
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
Name Current Vs Industry Vs History
Cash-To-Debt 17.87
Equity-to-Asset 0.89
Debt-to-Equity 0.06
Debt-to-EBITDA 7.41
Interest Coverage 0.57
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.7
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 251.5
3-Year Book Growth Rate 51.5
Name Current Vs Industry Vs History
5-Day RSI 56.96
9-Day RSI 54.69
14-Day RSI 54.02
6-1 Month Momentum % 37.63
12-1 Month Momentum % 24.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.69
Quick Ratio 12.69
Cash Ratio 12.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -30.3

Financials (Next Earnings Date:2022-11-15 Est.)

SNDX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SNDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 138.951
EPS (TTM) ($) 0.16
Beta 0.84
Volatility % 56.8
14-Day RSI 54.02
14-Day ATR ($) 1.104915
20-Day SMA ($) 23.687
12-1 Month Momentum % 24.3
52-Week Range ($) 13.27 - 25.7078
Shares Outstanding (Mil) 56.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syndax Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Syndax Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.